Zusammenfassung
Der menschliche Haarfollikel ist ein komplexes Anhangsgebilde der Haut, das sich aus zahlreichen verschiedenen Zellpopulationen zusammensetzt. Während des Wachstumsprozesses folgt der menschliche Haarfollikel einem charakteristischen, lebenslang sich wiederholenden Wechselspiel zwischen 2–6 Jahre dauernder Wachstumsphase (Anagen), einer in wenigen Wochen ablaufenden Übergangsphase (Katagen) und einer 2–3 Monate anhaltenden Ruhephase (Telogen). Jeder einzelne Haarfollikel durchläuft diese 3 Phasen individuell, sodass das Haarwachstum aller Haarfollikel asynchron verläuft und beim Menschen einem nur noch gering zu bemerkenden Jahreszyklus unterliegt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur zu Kapitel 58.2–58.3
Bergfeld WF (1995) Androgenetic alopecia: an autosomal dominant disorder. Am J Med 98:95S-98S
Blume-Peytavi U (1996) Die Kontrolle des Haarzyklus: Stellenwert und Bedeutung der dermalen Papille. Z Hautkr 6: 410–415
Blume-Peytavi U, Orfanos CE (2000) Síndrome SAHA. En: Piquero-Martin (ed) Acné, Manejo Racional, 3. ed. Editorial Corpográfica, Caracas, pp 121–130
Chen W, Zouboulis CC, Orfanos CE (1996) The 5-reductase system and its inhibitors. Dermatology 193:177–184
Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF et al. (1996) Guidelines of care for androgenetic alopecia. J Am Acad Dermatol 35:465–469
Kaufmann KD, Olsen EA, Whiting D, Savin R, DeVillez R et al. (1998) Finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Am Acad Dermatol 36:578–589
Meidan VM, Touiton E (2001) Treatments for androgenetic alopecia and alopecia areata: current options and future prospects. Drugs 61:53–69
Niryama S, Kojima K, Hamada T et al. (2000) The novel drug CS-891 inhibits 5 alpha-reductase activity in freshly isolated dermal papilla of human hair follicles. Eur J Dermatol 10:593–595
Orfanos CE (1991) Alopecia androgenetica. Klinische Aspekte. In: Orfanos CE (Hrsg) Haar und Haarkrankheiten, 2. Aufl. Gustav Fischer, Stuttgart New York, S 573–604
Orfanos CE, Vogels L (1980) Lokaltherapie der Alopecia androgenetica mit 17α-Östradiol. Dermatologica 161: 124–132
Paik JH, Yoon Sb, Sim WY et al. (2001) The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol 145:95–99
Sawaya ME, Price VH (1997) Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 109: 296–300
Schell H, Kiesewetter F, Hornstein OP (1994) Haarwuchsmittel bei androgenentischer Alopezie: Anspruch und Realität. Hautarzt 45:360–363
Walsh DS, Dunn CL, James WD (1995) Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride. Arch Dermatol 131:1373–1375
Wolff H, Kunte C (1998) Die Behandlung der androgene-tischen Alopezie des Mannes mittels systemischer 5 a-Reduktase-Hemmung. Hautarzt 49: 813–817
Alabdulkareem A, Abahussein A, Okoro A (1998) Severe alopecia areata treated with systemic corticosteroids. Int J Dermatol 37: 622–624
Ashworth J, Tuyp E, Mackie RM (1989) Allergic and irritant contact dermatitis compared in the treatment of alopecia totalis and universalis. A comparison of the value of topical diphencyprone and tretinoin gel. Br J Dermatol 120:397–401
Baar van HM, Vleuten van der CJ, Kerkhof van der PC (1995) Dapsone versus topical immunotherapy in alopecia areata. Br J Dermatol 133: 270–274
Berth-Jones J, Hutchinson P (1991) Alopecia totalis does not respond to the vitamin D analogue calcipotriol. J Dermatol Treat 1:293
De Waard-van der Spek F, Oranje A, Raeymaecker de D, Peereboom-Wynia J (1989) Juvenile versus maturity-onset alopecia areata. A comparative retrospective clinical study. Clin Exp Dermatol 14:429–433
Ead R (1981) Oral zinc sulphate in alopecia areata-a double blind trial. Br J Dermatol 104: 483–484
Fiedler-Weiss V, Buys C (1987) Evaluation of anthralin in the treatment of alopecia areata. Arch Dermatol 123: 1491–1493
Friedli A, Labarthe MP, Engelhardt E, Feldmann R, Salomon D, Saurai JH (1998) Pulse methylpredniso-lone therapy for severe alopecia areata: an open prospective study of 45 patients. J Am Acad Dermatol 39: 597–602
Galbraith GM, Thiers BH, Jensen J, Hoehler F (1987) A randomized double blind study of inosiplex therapy in patients with alopecia totalis. J Am Acad Dermatol 16: 977–983
Gilhar A, Pillar T, Etzioni A (1989) Topical cyclosporin A in alopecia areata. Acta Derm Venereol 69: 252–253
Gollnick H, Orfanos CE (1990) Alopecia areata: pathogenesis and clinical picture. In: Orfanos CE, Happle R (eds) Hair and hair diseases. Springer, Berlin Heidelberg New York, pp 529–570
Gupta AK, Ellis CN, Cooper KD, Nickoloff BJ, Ho VC et al. (1990) Oral cyclosporine for the treatment of alopecia areata: a clinical and immunohistochemical analysis. J Am Acad Dermatol 22: 242–250
Healy E, Rogers S (1993) PUVA treatment for alopecia areata-does it work? A retrospective study of 102 cases. Br J Dermatol 129:42–44
Hoffmann R, Happle R (1999) Alopecia areata. Teil 2: Therapie. Hautarzt 50:310–315
Lassus A, Kianto U, Johansson E, Juvakoski T (1980) PUVA treatment for alopecia areata. Dermatologica 161: 298–304
Lassus A, Eskelinen A, Johansson E (1984) Treatment of alopecia areata with three different PUVA modalities. Photodermatology 1:141–144
Madani S, Shapiro I (2000) Alopecia areata update. J Am Acad Dermatol 42:549–566
Magee KL, Hsu SM, Trucker SB (1990) Trial of intralesional interferon alpha in the treatment of alopecia areata. Arch Dermatol 126:760–762
McElwee KJ, Rushton DH, Trachy R, Oliver RF (1997) Topical FK 506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model. Br J Dermatol 137:491–497
Meidan VM, Toniton E (2001) Treatments for androgenetic alopecia: current options and future prospects. Drugs 61: 53–69
Milgraum S, Mitchell A, Bacon H (1987) Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age and younger. J Am Acad Dermatol 17:57–61
Pericin M, Trüeb R (1998) Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: evaluation of 68 cases. Dermatology 196: 418–421
Peter C, Hoting E (1996). Therapie der Alopecia areata mit Zinksulfat — eine placebokontrollierte Studie an 307 Patienten. Z Hautkr 71/3:175–189
Prost de Y, Teillac D, Paquez F, Carrugi L, Bachelez H, Touraine R (1986) Placebo controlled trial of topical cyclosporin in severe alopecia areata. Lancet II: 803–804
Rokhsar C, Shupack J, Vafai J, Washenik K (1998) Efficacy of topical sensitizers in the treatment of alopecia areata. J Am Acad Dermatol 39:751–761
Seiter S, Ugurel S, Tilgen W et al. (2001) High dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology 202:230–234
Shapiro J (1993) Alopecia areata: update on therapy. Dermatol Clin 11:35–46
Taylor C, Hawk J (1995) PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years’ experience at St John’s institute of dermatology. Br J Dermatol 133:914–918
Yamamoto S, Kato R (1994) Hair growth-stimulating effects of cyclosporine A and FK506, potent immunosuppressants. J Dermatol Sci 7: S47–54
Winter R, Kern F, Blizzard R (1976) Prednisone therapy for alopecia areata. A follow-up report. Arch Dermatol 112: 1549–1552
Abeck D, Korting HC, Braun-Falco O (1992) Folliculitis decalvans. Long-lasting response to combined therapy with fusidic acid and zinc. Acta Derm Venereol 72:143–145
Allen HB, Honig PJ, Leyden JJ, Mc Ginley KJ (1982) Selenium sulfide: Adjunctive therapy for tinea capitis. Pediatrics 69:81–83
Bergner T, Braun-Falco O (1991) Pseudopelade of Brocq. J Am Acad Dermatol 25: 865–866
Brozena SJ, Cohen LE, Fenske NA (1988) Folliculitis decal-vans-response to rifampicin. Cutis 42:512–515
Bulengo-Ransby SM, Headington JT (1990) Pseudopelade of Brocq in a child. J Am Acad Dermatol 23:944–945
Civatte J, Belaich S, Bonvalet D (1991) Lichen planus und lichenoide Reaktionen. In: Orfanos CE (Hrsg) Haar und Haarkrankheiten, 2. Aufl. Fischer, Stuttgart, S 681–698
Goerz G, Kind R (1991) Narbige Alopezien. In: Orfanos CE (Hrsg), Haar und Haarkrankheiten, 2. Aufl. Fischer, Stuttgart, S 605–641
Graham-Little E (1921) A case of lichen spinulosus with folliculitis decalvans. Br J Dermatol 33: 268
Headington JT (1996) Cicatricial alopecia. Dermatol Clin 14: 773–782
Hermes B, Paus R (1998) Vernarbende Alopezien. Anmerkungen zur Klassifikation, Differentialdiagnose und Pathobiologie. Hautarzt 49:462–472
Kossard S (1994) Postmenopausal frontal fibrosing alopecia: scarring alopecia in a pattern distribution. Arch Dermatol 130:770–774
Kossard S, Lee MS, Wilkinson B (1997) Postmenopausal frontal fibrosing alopecia: a frontal variant of lichen planopilaris. J Am Acad Dermatol 36:59–66
Legendre R, Esola-Macre J (1990) Itraconazole in the treatment of tinea capitis. J Am Acad Dermatol 23:559–560
Lyman CA, Walsh TJ (1992) Systemically administered antifungal agents. Drugs 44:9–35
Matta M, Kibbi A, Khattar J, Salman S, Zaynoun S (1990) Lichen planopilaris: a clinicopathologic study. J Am Acad Dermatol 22:594–598
Powell JJ, Dawber RP, Gatter K (1999) Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol 140:328–333
Schwarzenbach R, Djawari D (1998) Pseudopelade Brocq -mögliche Folge einer Borreliose Stadium III? Hautarzt 11: 835–837
Sullivan JR, Kossard S (1998) Acquired scalp alopecia. Part I. A review. Australas J Dermatol 39: 207–219
Trüeb R (1997) Vernarbende Alopezien: Diagnostik und Therapie. Schweiz Rundsch Med Prax 86: 987–992
Trüeb R, Torricelli R (1998) Lichen planopilaris unter dem Bild einer postmenopausalen frontalen fibrosierenden Alopezie (Kossard). Hautarzt 49:388–391
Wilson C, Burge S, Dean D, Dawber R (1992) Scarring alopecia in discoid lupus erythematosus. Br J Dermatol 126:307–314
Yell JA, Mbuagbaw J, Burge SM (1996) Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol 135: 355–362
Berth-Jones J, Shuttleworth D, Hutchinson PE (1990) A study of etretinate alopecia. Br J Dermatol 122:751–755
Budde J, Tronnier H, Rahlfs VW, Frei-Kleiner S (1993) Systemic therapy of diffuse effluvium and hair structure damage. Hautarzt 44:380–384
Dahlin PA, George J, Nerette JC (1984) Telogen effluvium: hair loss after spinal cord injury. Arch Phys Med Rehabil 65: 485–486
Gollnick H, Blume U, Orfanos C (1990) Unerwünschte Arzneimittelwirkungen am Haar. Z Hautkr 65:1128–1134
Hertel H, Gollnick H, Matthies C, Baumann I, Orfanos CE (1989) Niedrig dosierte Retinol- und Cystin-Kombina-tion bessern die Alopezie vom diffusen Typ nach peroraler Langzeit-Applikation. Hautarzt 40: 490–495
Mahrle G, Orfanos CE, Ippen H, Hofbauer M (1979) Haarwachstum, Leberwerte und Lichtempfindlichkeit unter oraler Retinoid-Therapie bei Psoriasis. Dtsch Med Wochenschr 104:473–477
McKinney PA, Finkenbine RD, DeVane CL (1996) Alopecia and mood stabilizer therapy. Ann Clin Psychiatry 8: 183–185
Orfanos CE, Gerstein E, Runne U (1976) Der zytostatische Haarverlust als biologisches Modell. Zystostatika-Wirkung auf gesunde Körperzellen. Dtsch Med Wochenschr 40:1465–1468
Petri H, Pierchalla P, Tronnier H (1990) The efficacy of drug therapy in structural lesions of the hair and in diffuse effluvium-comparative double blind study. Schweiz Rundsch Med Prax 79:1457–1462
Shuster S (1972) Psoriatic alopecia. Br J Dermatol 87:74–77
Tosi A, Misiciali C, Piraccini BM, Peluso AM, Bardazzi F (1994) Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf 10:310–317
Whiting DA (1996) Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 35: 899–906
Zaun H (1990) Diagnostik und Therapie des diffusen Haarausfalls. Z Hautkr 65/12:1092–1095
Blume-Peytavi U, Mandt N (2000) Hair shaft abnormalities. In: Hordinsky M, Sawaya M, Scher S (eds) Atlas of the Hair and Nails. Churchill Livingstone, Philadelphia, pp 105–119
Bulengo-Ransby SM, Bergfeld WF (1990) Chemical and traumatic alopecia from thioglycate in a black woman: a case report with unusual clinical and histologic findings. Cutis 49:99–103
Hwang SM, Lee WS, Choi EH et al. (1999) Nurse’s cap alopecia. Int J Dermatol 38:187–191
Lachapelle J, Pierard G (1977) Traumatic alopecia in trichotillomania: a pathogenic interpretation of histologic lesions in the pilosebaceous unit. J Cutan Pathol 4:51–67
Meiers H (1971) Trichotemnomanie. Hautarzt 22:335–337
Minichiello W, O’Sullivan R, Osgood-Hynes D, Baer L (1994) Trichotillomania: Clinical aspects od treatment and strategies. Harvard Rev Psychiatry 1:336–344
Nicholson AG, Harland CC, Bull RH, Mortimer PS, Cook MG (1993) Chemically induced cosmetic alopecia. Br J Dermatol 128:537–541
Trüeb R, Cavegn B (1996) Trichotillomania in connection with alopecia areata. Cutis 58: 67–70 Whiting DA (1999) Traumatic alopecia. Int J Dermatol 38 (Suppl. 1): 34–44
Bencini P, Lud A, Galimberti M, Ferranti G (1999) Long-term epilation with long-pulsed neodimium: YAG-Laser. Dermatol Surg 25:175–178
Dawber R (1994) Facial and body hair. In: Baran R, Maibach H (eds) Cosmetic dermatology. Martin Dunitz, Baltimore, pp 139–142
Esperanza LE, Fenske NA (1996) Hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) syndrome: Spontaneous remission in a 15-year-old girl. J Am Acad Dermatol 34:892–897
Farina MC, Tarin N, Grilli R, Soriano ML, Sarasa JL et al. (1998) Acquired hypertrichosis lanuginosa: case report and review of the literature. Surg Oncol 68:199–203
Grossman M, Dierickx C, Farinelli W, Flotte T, Anderson R (1996) Damage to hair follicles by normal-mode ruby laser pulses. J Am Acad Dermatol 35: 889–894
Hasan A, Eaglstein W, Pardo R (1999) Solar-induced postinflammatory hyperpigmentation after laser hair removal. Dermatol Surg 25:113–115
Lask G, Elman M, Slatkine M, Waldman A, Rozenberg Z (1997) Laser-assisted hair removal by selective photother-molysis. Preliminary results. Dermatol Surg 23:737–739
Olsen E (1999) Methods of hair removal. J Am Acad Dermatol 40:143–155
Orfanos CE, Hertel H (1988) Haarwachstumsstörungen bei Hyperprolaktinämie. Z Hautkr 63:23–26
Plantin P, Schoenlaub P, Dupre D, Le Fur J (1998) Shaving: a simple and effective treatment for moderate congenital hypertrichosis. Eur J Dermatol 8:189–190
Richards R, Meharg G (1995) Electrolysis: observations from 13 years and 140.000 hours of experience. J Am Acad Dermatol 33: 662–666
Sommer S, Render C, Burd R, Sheehan-Dare RA (1998) Ruby laser treatment for hirsutism: clinical response and patient tolerance. Br J Dermatol 138:1009–1014
Tosti A, Misiciali C, Piraccini BM, Peluso AM, Bardazzi F (1994) Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf 10:310–317
Weiss RA, Weiss MA, Marwaha S, Harrington AC (1999) Hair removal with a non-coherent filtered flashlamp intense light source. Lasers Surg Med 24:128–132
Bouillon C (1996) Shampoos. Clin Dermatol 14:113–121
Budde J, Tronnier H, Rahlfs VW, Frei-Kleiner S (1993) Die systemische Therapie des diffusen Effluviums und Schäden der Haarstruktur. Hautarzt 44:380–384
Dawber R (1996) Hair: its structure and response to cosmetic preparations. Clin Dermatol 14:105–112
Domsch A, Pospischil H, Schuster G, Tronnier H (1980) Kosmetisch-dermatologische Wirkung von Eiweißhydroly-saten. Parfüm Kosmet 61:325–330
Hertel H, Gollnick H, Matthies C, Baumann I, Orfanos CE (1989) Niedrig dosierte Retinol und L-Cystin-Kombi-nation bessern die Alopezie vom diffusen Typ nach peroraler Langzeit-Applikation. Hautarzt 40:490–495
Mahrle G, Orfanos CE (1973) Haarfarbe und Haarpigment. Elektronenmikroskopische Untersuchungen am Natur-und gebleichten Haar. Arch Dermatol Forsch 248:109–122
Orfanos CE (1971) Der Aufbau des gesunden und das krankhaft veränderten Haares. Kosmetologie 3:90–94
Orfanos CE, Imcke E (1990) Haar und Haarkosmetika. In: Hair and hair diseases. Orfanos CE, Happle R (eds) Springer Verlag, Berlin Heidelberg New York, pp 887–925
Rebenfeld L, Weigmann H, Dansizer C (1966) Temperature dependence of the mechanical properties of human hair in relation to structure. J Soc Cosm Chem 17:525
Rushton H, Gummer C, Flasch H (1994) 2-in-1-shampoo technology: state of the art shampoo and conditioner in one. Skin Pharmacol 7:78–83
Trüeb R (1998) Haarwaschmittel (Shampoos): Zusammensetzung und klinische Anwendung. Hautarzt 49:895–901
Trüeb R (2001) The value of hair cosmetics and pharmaceuticals. Dermatology 202: 275–282
Urbano C (1995) 50 years of hair care development. Cosmet Toiletries 110:85–104
Zesch A (1999) Kosmetika. Definition und rechtliche Grundlagen der Anwendung. Hautarzt 50:243–249
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Orfanos, C.E., Garbe, C. (2002). Häufige Haarkrankheiten. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_58
Download citation
DOI: https://doi.org/10.1007/978-3-642-56219-8_58
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62541-1
Online ISBN: 978-3-642-56219-8
eBook Packages: Springer Book Archive